Feature | Artificial Intelligence | May 13, 2019

Artificial Intelligence Adoption in Radiology and Cardiology is Focus of June Conference

AIMed conference aims to increase collaboration and speed adoption of AI in medicine

AIMed conference in artificial intelligence in radiology, medical imaging.

The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical conferences for radiology, cardiology and several other subspecialties over the past two years. This has led to the creation of an organization AIMed to help spearhead collaboration and dissemination of information on AI developments to speed its adoption. 

The 2019 AIMed Radiology/Cardiology conference in June is in Chicago is aimed at those interested in the use of artificial intelligence (AI) and deep learning in advanced medical imaging. The conference also allows attendees to experience the future of radiology using augmented and virtual reality and to understand the future of medical education and training with AI. 

The conference is June 18-19, 2019, at the Ritz-Carlton Chicago. The event is expected to draw 1,800 attendees, 350 speakers and about 1,500 companies, including start-ups and some of the key players bringing AI into Healthcare.

This is the largest event of its type in the United States focused on AI in medicine. The conference offers two days dedicated to the transformative impact that AI-inspired technology is having on radiology. Artificial Intelligence has the power to transform radiological and cardiology practice. AIMed said the benefits of machine learning and deep neural networks in identifying disease earlier and more accurately will greatly aid patient care. The integration of this technology at scale is, however, more challenging. AIMed said some key questions it hopes to answer is how do we invest in building the necessary frameworks to validate these tools in the clinical setting? How do we ensure we are working in unison as an industry and not in a siloed and duplicative fashion? And, how do we ensure we maintain physician oversight/domain expertise when these tools are being developed?

AIMed is a collaborative organization that aims to bring together radiologists, hospital leaders and technology experts so they can start a revolution in today’s medicine and healthcare for a data-smart tomorrow. In order to achieve that goal, AIMed is are constantly on the look out for anyone moving the needle in this field.

The event is targeting radiologists, hospital leaders, data scientists and Health AI innovators.

For more information on the event: https://aimed.events/aimed-radiology-2019/

Registration for the event: https://aimed.eventscase.com/attendance/event/index/34570/EN

Event Agenda: https://aimed.events/wp-content/uploads/2019/02/AIMed-Radiology.pdf

 

Related AIMed Content:

VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul J. Chang, M.D.

VIDEO: Artificial Intelligence Applications for Cardiology  — Interview with AIMed Founder  Anthony Chang, M.D.

PODCAST: Fitting Artificial Intelligence Into Cardiology — Interview with AIMed Founder  Anthony Chang, M.D.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 07, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Surgeon General Jerome Adams, M.D., M.Ph demonstrates how the general public can make their own face masks for non-clinical use.

U.S. Surgeon General Jerome Adams, M.D., M.Ph. demonstrates how the general public can make their own face masks for non-clinical use.

News | Coronavirus (COVID-19) | April 04, 2020 | By Melinda Taschetta-Millane
April 4, 2020 — The Centers for Disease Control and Prevention (CDC)
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...